LEIDOS, INC.
Federal contract award, Leidos, $157,691
Key CONT_AWD_HT942524F0287_9700_HT942523D0002_9700. First seen by this system September 5, 2026 through the historical sweep, new to the watchlist, public 213 days before this system saw it. One version on record.
Cite this row
842a03299a4188d3203c8cfc57c803f87e75dc0e7768d27a49f4729f83921145The source record can change after this date; the key, hash and retrieval time name exactly the response this system stored. See license and citation.
Versions
| Version | Amount | Change | Occurred | Published | Retrieved | How it arrived | Content hash |
|---|---|---|---|---|---|---|---|
| 1 current | $157,691 | first version | September 4, 2024 | February 4, 2026 | 2026-09-05T00:58:36Z | historical sweep | 842a03299a41 |
Archived copy
https://web.archive.org/web/20261020011159/https://www.usaspending.gov/award/CONT_AWD_HT942524F0287_9700_HT942523D0002_9700 captured by this system, October 20, 2026
What the amount is made of
6 recorded actions, so the amount is the award's current total across all of them. 3 of them obligated money. Measured 2026-10-04, when USAspending reported a total obligation of $157,691.
| Action date | Modification | Type | Obligated | Description as recorded |
|---|---|---|---|---|
| July 29, 2025 | P00005 | FUNDING ONLY ACTION | −$128,530 | COST-TO-COMPLETE FOR FISCAL YEAR 2024 GLIOBLASTOMA RESEARCH PROGRAM |
| May 22, 2025 | P00004 | TERMINATE FOR CONVENIENCE (COMPLETE OR PARTIAL) | no money | GLIOBLASTOMA SUPPORT SERVICES |
| February 13, 2025 | P00003 | FUNDING ONLY ACTION | +$38,346 | FISCAL YEAR 2024 GLIOBLASTOMA RESEARCH PROGRAM VISION SETTING, PRE-APPLICATION SCREENING, PROGRAMMATIC REVIEW AND GENERAL PROGRAM SUPPORT |
| January 27, 2025 | P00002 | SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | no money | FISCAL YEAR 2024 GLIOBLASTOMA VISION SETTING, PROGRAMMATIC REVIEW, AND GENERAL PROGRAM SUPPORT |
| September 9, 2024 | P00001 | OTHER ADMINISTRATIVE ACTION | no money | FY24 GLIOBLASTOMA SUPPORT OF VISION SETTING, PRE-APPLICATION SCREENING, PROGRAMMATIC REVIEW AND GENERAL PROGRAM SUPPORT. |
| September 4, 2024 | base | not on file | +$247,874 | FISCAL YEAR 2024 GLIOBLASTOMA MEDICAL RESEARCH PROGRAM GENERAL PROGRAM SUPPORT, VISION SETTING, PROGRAMMATIC REVIEW SUPPORT. |
Last refreshed November 4, 2026 at 2:31 PM UTC.